Knowledge base
Archived articles from Synergus RWE, kept for reference.
22 articles
Integration of Treatment council to The Danish Healthcare Quality Institute (DHQI) - Impacting Medtech and Diagnostics
The integration of the Treatment Council (Behandlingsrådet) into the Danish Healthcare Quality Institute (DHQI) provides an important development for Medtech and Diagnostics. The DHQI has a broader scope, including:…
Status update: Digital Health Frameworks in Europe
We are continuing our work to collect data from HTA agencies regarding dedicated frameworks. After the initial distribution of the survey, this is our current status. Green: Response received from all agencies Yellow:…
Transferring Outcomes Data: The Illusion of Simplicity - Variation in stroke health outcomes and healthcare delivery
This blogpost takes stroke care as an example to demonstrate the differences observed in health outcomes and resource distribution, 1-year post-stroke. This example is based on data from Sweden, categorized by region.…
Transferring Outcomes Data: The Illusion of Simplicity - A Case Study comparing Breast Cancer outcomes and care delivery
Breast Cancer – Part 3 In this blog series we are analysing different aspects of the transferability of disease outcomes, either from RCT to Real-World setting or between different settings/countries. If you missed the…
Transferring Outcomes Data for National Decision Making: The Illusion of Simplicity - The whole world should use validated Swedish Data, or maybe not….
This blog is part of our series on the issues related to the transferability of outcomes, for national decision making. You can follow this link to read our other blog posts on this topic. The ongoing discussion about…
Transferring Outcomes Data for National Decision Making: The Illusion of Simplicity What is the HTA perspective on transferability?
This is a blog in our series about the issues relating to the transferability of outcomes for national decision making. Click on this link to get the other posts related to this topic. In this blog post we will provide…
Transferring Outcomes Data for National Decision Making: The Illusion of Simplicity
Variation in outcomes and health care delivery Breast Cancer – Part 2 In this blog-post series we are analysing different aspects about transferability of outcomes, either from RCT to Real-World setting or between…
Transferring Outcomes Data for National Decision Making: The Illusion of Simplicity - Understanding why healthcare delivery is a significant issue
This blog is part of our series on the issues related to the transferability of outcomes, for National decision making. You can follow this link to read our other posts within this topic. To illustrate the impact and…
Transferring Outcomes Data: The Illusion of Simplicity
As previously announced , we have started a project that will look at issues relating to “Methodological aspects of evaluating transferability of Real World Evidence results between countries / settings”. As part of…
The Model for Assessment of Telemedicine (MAST) – Leveraging EUnetHTA framework to assess the value of e-health / telemedicine
This blog is to provide a brief background to the coming webinar by Dr Kristian Kidholm about the topic “HTA evaluation of e-health solutions ” based on the The Model for Assessment of Telemedicine (MAST). The MAST…
Synergus analyzed the data and recommendations from 10 latest HTA reports in Sweden
Synergus’ analysis included the 10 latest HTA reports by different national and regional HTA bodies in Sweden. The reports covered various disease areas and technology areas, most of them related to treatment and…
2016 Overview of HTA reports for Medical Devices and In-Vitro Diagnostics
HTA plays an increasingly important role for Medical Device and IVD companies. Below is a summary of the HTA Dynamics during 2016, followed by the same data for 2015. The total amount of HTA evaluations have reduced…
HTA evaluations for imaging devices
We have recently reviewed the number of HTA reports regarding imaging modalities. We can see somewhat of a reduction during 2015 compared to 2014. The trend for the first 4 months of 2016 would indicate an increase…
Introduction of benefit assessment requires complete rethink about how to handle nub-applications for new interventions
There are many aspects that are changing with the introduction of the new 137h process to assess the benefit of the new innovations coming to market. We will provide more information about all of these changes in a…
The changing landscape in Germany regarding HTA assessments
The changing landscape in Germany regarding HTA assessments The German landscape for introduction of new technologies and drugs is changing dramatic. For drugs, the introduction of the Amnog process has been a drastic…
HTA evaluations in the United Kingdom
An overview of the HTA activity by different organisations in the United Kingdom. For NICE, we have only included the reports, we consider to be HTA like evaluation and not clinical guidelines. In the last 12 months,…
Dutch HTA
An overview of the HTA activity by the Dutch Zorginstituut, who will now have the important role of beeing EUnetHTA Secretariat. In the last 12 months, the 3 most frequent companies in the reports have been Pfizer,…
French HTA evalutions
The French Haute Autorité de Santé is one of the HTA organisations in Europe with most publications. 3,6% of their publications are HTA reports and 96,4 % are reimbursement evaluations of individual drugs or…
Nordic HTA activity
In the below graphs, you can see the HTA activity in the Nordic countries. Particullary interesting to see the increased used of mini-HTA assessments in Norway and Sweden. HTA Update
Health technology assessments of in-vitro diagnostic tests
This study revealed similarities in evidence requirements for in-vitro diagnostic tests in health technology assessments in England and France. However, economic evidence is not a part of French assessments of new codes…
Use of generic quality of life measures in reports from NICE
We are evolving the insight in the data we have in our HTA update search platform. In this analysis we looked at the occurrence of the two major quality of life measures, EQ-5D and SF-36, in reports from NICE in the…
More than 50% of health technology assessments of medical devices in Europe are performed outside INAHTA members
In total 301 out of 573 HTAs performed in 2013-2014 for medical devices in Europe were originated from non-INAHTA members. Countries with the most reports published by non-INAHTA members are Denmark (86%), Netherlands…